Who We Are
Onegene Biotechnology develops transformative therapeutics for the chronic and complex diseases. Our UniStac platform allows rationale-based design of multispecific drug in true plug-and-play manner.
-
01
Established
-
09
Seed Fund closed
Selected on a TIPS Project
by Ministry of SMEs and StartupsTech incubator program for startups
· Selects potential startups and supports collaborations with private investments and governmental R&D units, in order to encourage new business establishments by high-quality human resources -
12
Registered “Platform technology patent”
-
08
Pre-series A funded (USD 3.5m)
-
09
PCT applied for platform technology
-
11
Awarded from the 2020 BioChallenge sponsored by Cytiva
One of the largest bio-awards in Korea, hosted by KoreaBIO and sponsored by MoH/Cytiva
· Selects promising Korean biotech with purpose to discover and support potential leaders of the emerging global bio industry
-
02
Series A funded (USD 12.5m)
-
08
Selected on a project by Korea Drug Development Fund (KDDF)
Pan-governmental R&D project named as the ‘Fund for establishment of ecosystem for new drug R&D
· Supports development and commercialization of new drug candidates, in order to enhance national competitiveness in new drug R&D sector
-
03
Series B funded (USD 33.5m)